Page last updated: 2024-09-03

brl 44408 and guanylyl imidodiphosphate

brl 44408 has been researched along with guanylyl imidodiphosphate in 1 studies

Compound Research Comparison

Studies
(brl 44408)
Trials
(brl 44408)
Recent Studies (post-2010)
(brl 44408)
Studies
(guanylyl imidodiphosphate)
Trials
(guanylyl imidodiphosphate)
Recent Studies (post-2010) (guanylyl imidodiphosphate)
820162,356118

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GarcĂ­a-Sevilla, JA; Sastre, M1

Other Studies

1 other study(ies) available for brl 44408 and guanylyl imidodiphosphate

ArticleYear
Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
    Journal of neurochemistry, 1994, Volume: 63, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding, Competitive; Brain; Dioxanes; Edetic Acid; Female; Guanabenz; Guanylyl Imidodiphosphate; Humans; Idazoxan; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Piperazines; Receptors, Adrenergic, alpha; Sodium Chloride; Tritium

1994